Navigation Links
HollisterStier Offers Comfort With New ComforTen(TM) Multiple Skin Testing Device
Date:11/9/2007

Provides 10 puncture skin tests at once with minimal patient discomfort

SPOKANE, Wash., Nov. 9 /PRNewswire/ -- HollisterStier's Allergy Business Unit announced today the launch of the ComforTen(TM) Multiple Skin Test System, its newest allergy testing device. The device features ten surgical steel 1.2mm lancet tips, which create minimal skin trauma for comfortable allergy testing. ComforTen is the only 10-test, self-loading, surgical steel testing device on the market. ComforTen is competitively priced relative to other multiple skin test devices available today. In addition to creating a more comfortable experience for the patient; little or no trauma at the negative control site makes it easy to read skin test reactions.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060228/SFTU141LOGO)

Derek Constable, Ph.D., Director of New Product Discovery at HollisterStier, said, "ComforTen was developed with the Allergists, nurses, and the patients in mind. We have made every effort to create a comfortable allergy testing experience for all parties. We're excited to introduce this new addition to the full suite of HollisterStier products."

In addition to the device itself, the ComforTen System includes trays with three optional-use spacers (patent pending) that increase the number of tests that can be completed between fillings. "We heard allergy offices tell us they wanted a skin testing device that maximized efficiency and the ComforTen System does that," Constable said. The trays are also supplied with self-adhesive labels allowing for customized tray labeling.

When used as directed, the ComforTen device with depth control guards will produce ten reproducible skin tests resulting in well-defined reactions. The device is equipped with directional indicators to help ensure the proper orientation and application.

About HollisterStier's Allergy Business
'/>"/>

SOURCE HollisterStier Laboratories LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation
2. Radio wave cooling offers new twist on laser cooling
3. Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015
4. Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies
5. Microtest Offers Free White Paper: Virus Testing for Biological Products: Partnering With a Contract Lab
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System
8. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
9. Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States
10. Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007
11. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014   Synthetic Biologics, ... novel pathogen-specific therapies for serious infections and diseases, announced ... issued a Notice of Allowance for a composition of ... C. difficile program, SYN-004. This is Synthetic ... in the U.S. and adds to the Company,s extensive ...
(Date:10/22/2014)... -- Nuvilex, Inc. (OTCQB: NVLX) – According to the ... living with diabetes, with  that number expected to grow ... for diabetes treatments is approximately $500 billion.  ... pancreatic cancer.  Pancreatic cancer is the fourth most common ... the United States , and according to a ...
(Date:10/22/2014)... and HONG KONG , Oct. 22, ... therapeutics enterprise, announced today that rare disease expert ... vice president, research. Dr. McKew brings more than two ... positions at the National Institutes of Health, Wyeth Research ... Wyeth). Dr. McKew will lead aTyr,s efforts to expand and ...
(Date:10/20/2014)... Oct. 20, 2014 Mapp Biopharmaceutical,s valiant ... antibody therapeutic to fight the Ebola outbreak will ... time-consuming the production of pharmaceuticals can be, according ... said that while some may be taken aback ... those with industry knowledge are well aware of ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3
... Sept. 7 On Thursday, October,18, 2007, Wyeth (NYSE: ... 2007,third quarter. The Company will hold a one-hour conference ... October 18, 2006. Interested,investors and others may listen to ... Internet webcast, which may be accessed by visiting our ...
... Richard Gabriel, Chief,Executive Officer of DNAPrint Genomics, ... be featured in an exclusive interview with, http://www.wallst.net ... September 10 at 11,a.m. EDT. The interview will ... p.m.,EDT on September 10. The interview will ...
... York City 5:30-7:30 p.m. (ET), SAN DIEGO, Sept. ... focused on developing products for,minimally disruptive surgical treatments for ... reception for institutional investors and,analysts at the Waldorf=Astoria Hotel ... 5:30 p.m. to 7:30 p.m. ET. The reception ...
Cached Biology Technology:WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics 2NuVasive to Host Investor Reception on September 11, 2007 2NuVasive to Host Investor Reception on September 11, 2007 3NuVasive to Host Investor Reception on September 11, 2007 4
(Date:10/22/2014)... discovery by Northwestern Medicine® scientists helps explain how bipolar ... to new drug therapies to treat the mental illness. ... -- the same method recognized with the 2014 ... into brain tissue from mice with bipolar-like behaviors. In ... discovered tiny "nanodomain" structures with concentrated levels of ANK3 ...
(Date:10/18/2014)... 2014 Psychological stress and stress-related psychiatric disorders are ... but the molecular mechanisms underlying this relation ... to the development of targeted preventive strategies ... devastating diseases. This work is presented at ... Berlin., Now an international group of researchers ...
(Date:10/17/2014)... Copenhagen have shown for the first time how bacteria ... patients, giving them the opportunity to get tremendous insights ... The study also discovered the bacterial growth in chronic ... or slowed down by the immune cells. The researchers ... helped "suffocate" the bacteria, forcing the bacteria to switch ...
Breaking Biology News(10 mins):Bipolar disorder discovery at the nano level 2Researchers find why depression and aging linked to increased disease risk 2Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2
... biochemists have developed an approach that allows them to ... in a protein. The scientists were then able ... protein based on structural information, a novel outcome that ... Academy of Sciences. , Professor of biochemistry John Markley, ...
... are so crucial to survival that the brains of all ... long enough to allow the animal to eat, drink -- ... from researchers at the University of Chicago, published early online ... that by activating "OFF" cells and shutting down "ON" cells ...
... classic "Flowers for Algernon," but adds a happy ending, UCLA ... reverse the attention deficits linked to the leading genetic cause ... Biology reports the findings, which were studied in mice bred ... , The results proved so hopeful, that the Food and ...
Cached Biology News:Scientist uses form to explain function of key building blocks of life 2Brainstem blocks pain to protect key behaviors 2Brainstem blocks pain to protect key behaviors 3Recreating 'Flowers for Algernon' with a happy ending 2Recreating 'Flowers for Algernon' with a happy ending 3
Mouse monoclonal [1241] to Parainfluenza Virus type 2...
Mouse monoclonal [0.N.509] to PCTAIRE2 ( Abpromise for all tested applications). entrezGeneID: 5128 SwissProtID: Q00537...
Parathyroid Hormone Receptor 2 [PTHR2]...
... the caudal-related homeobox family, is an intestine-specific ... differentiation in intestinal epithelial cells. It plays ... the phenotype of differentiated villus enterocytes as ... phenotype. Clone CDX2-88 reacts with a conserved ...
Biology Products: